Record Chinese biotech out-licensing meets rising US scrutiny

China’s emergence as a global biotechnology innovation hub has become a source of strategic concern in the United States, prompting policymakers in Washington to re-evaluate how to respond to its growing influence, according to a recent report by a leading analytics firm.
“The country’s latest biotechnology success is strategically important, with implications extending beyond healthcare innovation to include pharmaceutical supply-chain resilience, economic competitiveness and national...